Yestar Healthcare Holdings Company Limited (SEHK:2393) commences share repurchases on January 7, 2019 under the program mandated by the shareholders in the Annual General Meeting held on May 15, 2018. As per the mandate, the company is authorized to repurchase up to 217,520,000 shares, representing 10% of its issued share capital. The purpose for the buyback is to enhance the net asset value per share and/or earnings per share. The repurchases will be funded out of funds of the company legally available for the purpose of making the proposed purchases in accordance with the company’s memorandum and articles of association and the laws of the Cayman Islands. The authority shall expire at the earliest of the next Annual General Meeting, the date on which the next Annual General Meeting is required to be held or the date on which the authority is varied or revoked in a General Meeting. As of May 15, 2018, the company had 2,175,200,000 shares in issue.